| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-02-09 |
详情>>
股本变动：
变动后总股本9183.88万股
|
| 2021-02-09 |
详情>>
业绩披露：
2021年一季报每股收益1.06美元,归母净利润9650.00万美元,同比去年增长9.41%
|
| 2021-01-26 |
财报披露：
美东时间 2021-01-26 盘后发布财报
|
| 2020-11-25 |
详情>>
业绩披露：
2018年年报每股收益1.64美元,归母净利润1.50亿美元,同比去年增长-31.4%
|
| 2020-11-25 |
详情>>
业绩披露：
2020年年报每股收益2.96美元,归母净利润2.69亿美元,同比去年增长-7.78%
|
| 2020-09-14 |
股东大会：
将于2020-10-15召开股东大会
会议内容 ▼▲
- 1.Consider and vote on a proposal to approve and adopt the Agreement and Plan of Merger, dated as of August 2, 2020, by and among Varian Medical Systems, Inc. (“Varian”), Siemens Healthineers Holding I GmbH (“Siemens Healthineers Holding”), a wholly owned subsidiary of Siemens Healthineers AG (“Siemens Healthineers Parent”), Falcon Sub Inc., a direct wholly owned subsidiary of Siemens Healthineers Holding (“Merger Sub”) and, with respect to certain provisions, Siemens Medical Solutions USA, Inc. (the “Guarantor”), as it may be amended from time to time (the “merger agreement”), a copy of which is included as Annex A to the proxy statement of which this notice forms a part, and pursuant to which Merger Sub will be merged with and into Varian, with Varian surviving the merger as a wholly owned subsidiary of Siemens Healthineers Holding and an indirect wholly owned subsidiary of Siemens Healthineers Parent (the “merger”);
2.Approve an adjournment of the special meeting, if necessary or appropriate, to solicit additional proxies in favor of the proposal to approve and adopt the merger agreement if there are not sufficient votes at the time of such adjournment to approve and adopt the merger agreement;
3.Consider and vote on a proposal to approve, on a non-binding, advisory basis, certain compensation that will or may be paid or become payable to Varian’s named executive officers that is based on or otherwise relates to the merger.
|
| 2020-08-11 |
详情>>
业绩披露：
2020年三季报(累计)每股收益2.12美元,归母净利润1.93亿美元,同比去年增长-12.93%
|
| 2020-05-12 |
详情>>
业绩披露：
2020年中报每股收益1.45美元,归母净利润1.31亿美元,同比去年增长-31.49%
|
| 2020-02-11 |
详情>>
业绩披露：
2020年一季报每股收益0.97美元,归母净利润8820.00万美元,同比去年增长-14.53%
|
| 2019-12-20 |
股东大会：
将于2020-02-13召开股东大会
会议内容 ▼▲
- 1.to elect ten directors to serve until the 2021 Annual Meeting;
2.to approve, on an advisory basis, the compensation of our named executive officers as described in the accompanying Proxy Statement;
3.to approve the Varian Medical Systems, Inc. 2010 Employee Stock Purchase Plan, as amended (the “Amended ESPP”);
4.to ratify the appointment of PricewaterhouseCoopers LLP (“PwC”) as our independent registered public accounting firm for fiscal year 2020;
5.to transact any other business that properly comes before the Annual Meeting.
|
| 2019-11-25 |
详情>>
业绩披露：
2017年年报每股收益2.36美元,归母净利润2.19亿美元,同比去年增长-45.28%
|
| 2019-11-25 |
详情>>
业绩披露：
2019年年报每股收益3.21美元,归母净利润2.92亿美元,同比去年增长94.73%
|
| 2019-08-07 |
详情>>
业绩披露：
2019年三季报(累计)每股收益2.43美元,归母净利润2.21亿美元,同比去年增长560.30%
|
| 2019-05-08 |
详情>>
业绩披露：
2019年中报每股收益2.11美元,归母净利润1.92亿美元,同比去年增长590.54%
|
| 2019-02-05 |
详情>>
业绩披露：
2019年一季报每股收益1.13美元,归母净利润1.03亿美元,同比去年增长191.90%
|
| 2018-12-21 |
股东大会：
将于2019-02-14召开股东大会
会议内容 ▼▲
- 1.to elect nine directors to serve until the 2020 Annual Meeting;
2.to approve, on an advisory basis, the compensation of our named executive officers as described in the accompanying Proxy Statement;
3.to ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year 2019;
4.to transact any other business that properly comes before the Annual Meeting.
|
| 2018-07-16 |
详情>>
内部人交易：
KUO JOHN W共交易8笔
|
| 2017-12-29 |
股东大会：
将于2018-02-08召开股东大会
会议内容 ▼▲
- 1.to elect nine directors to serve until the 2019 Annual Meeting;
2.to approve, on an advisory basis, the compensation of our named executive officers as described in the accompanying Proxy Statement;
3.to approve our Fifth Amended and Restated 2005 Omnibus Stock Plan (the “Amended Stock Plan”);
4.to ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year 2018;
5.to transact any other business that properly comes before the Annual Meeting.
|
| 2016-12-30 |
股东大会：
将于2017-02-09召开股东大会
会议内容 ▼▲
- 1.to elect seven directors to serve until the 2018 Annual Meeting of Stockholders;
2.to approve, on an advisory basis, the compensation of our named executive officers as described in the accompanying Proxy Statement;
3.to hold an advisory vote on how frequently (every one, two or three years) you prefer we conduct an advisory vote of stockholders to approve the compensation of our named executive officers;
4.to approve our Fourth Amended and Restated 2005 Omnibus Stock Plan (the “Amended Stock Plan”) to (i) preserve our ability to receive tax deductions under Section 162(m) of the Internal Revenue Code (the “Code”) and (ii) set a limit on the total value of equity and cash compensation that may be paid to each of our non-employee directors each fiscal year;
5.to ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year 2017;
6.to transact any other business that properly comes before the Annual Meeting.
|
| 2015-12-30 |
股东大会：
将于2016-02-11召开股东大会
会议内容 ▼▲
- 1.to elect three directors to serve until the 2017 Annual Meeting of Stockholders;
2.to approve, on an advisory basis, the compensation of our named executive officers as described in the accompanying Proxy Statement;
3.to ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year 2016;
4.to transact any other business that properly comes before the Annual Meeting.
|
| 2014-12-30 |
股东大会：
将于2015-02-12召开股东大会
会议内容 ▼▲
- 1.to elect three directors to serve until the 2018 Annual Meeting of Stockholders;
2.to provide an advisory vote on the compensation of our named executive officers as described in the accompanying Proxy Statement;
3.to ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year 2015;
4.to transact any other business that properly comes before the annual meeting.
|
| 2014-01-06 |
股东大会：
将于2014-02-20召开股东大会
会议内容 ▼▲
- 1. to elect four directors to serve until the 2017 Annual Meeting of Stockholders;
2. to provide an advisory vote on the compensation of our named executive officers as described in the accompanying Proxy Statement;
3. to approve the Varian Medical Systems, Inc. Management Incentive Plan;
4. to ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year 2014;
5. to amend our certificate of incorporation to declassify the Board;
6. to amend our certificate of incorporation to eliminate cumulative voting for directors;
7. to transact any other business that properly comes before the annual meeting.
|
| 2012-12-28 |
股东大会：
将于2013-02-14召开股东大会
会议内容 ▼▲
- 1.to elect three directors to serve until the 2016 Annual Meeting of Stockholders
2.to provide an advisory vote on the compensation of our named executive officers as described in the accompanying Proxy Statement
3.to ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year 2013
4.to act upon a stockholder proposal, if properly presented at the annual meeting
5.to transact any other business that properly comes before the annual meeting.
|